ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Owens New President Of AACI, Yates President Elect; UNC Gains Comprehensive Center Status

June 29, 1990

NCI to Host SBIR Investor Forum

November 7, 2014

Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.

January 25, 2002

Bristol-Myers Cancer Scientist Award Nominations To Close March 1

February 24, 1978

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977

In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH

July 23, 1999